The 100 most frequently cited articles in ophthalmology journals

Archives of Ophthalmology

Volumn 125, Issue 7, 2007, Pages 952-960

  Ohba, Norio ^a   Nakao, Kumiko ^b   Isashiki, Yasushi ^a   Ohba, Ayako ^a  

^a AICHI SHUKUTOKU UNIVERSITY   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETIC RETINOPATHY; GLAUCOMA; HUMAN; LASER COAGULATION; LIGHT REFRACTION; OPHTHALMOLOGY; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HOLE; RETINITIS; SCIENTIFIC LITERATURE; SCISEARCH; SUBRETINAL NEOVASCULARIZATION; UNITED STATES; VITRECTOMY;

BIBLIOMETRICS; OPHTHALMOLOGY; PERIODICALS; PUBLISHING;

EID: 34447522210     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.7.952     Document Type: Article

References (104)

1. Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA. 1987;257(1):52-59.
2. Thomson Scientific ISI Web of Knowledge: the new face of research. http://scientific.thomson.com/webofknowledge. Accessed August 20, 2006.
3. Ferris FL III, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol. 1982;94(1):91-96.
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy, II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520-526.
5. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1992;99(6):933-943.
6. Quigley HA, Addicks EM, Green WR. Optic nerve damage in human glaucoma, III: quantitative correlation of nerve fiber loss and visual-field defect in glaucoma, ischemic neuropathy, papilledema, and toxic neuropathy. Arch Ophthalmol. 1982;100(1):135-146.
7. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy, III: prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527-532.
8. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP report [published correction appears in Arch Ophthalmol. 2000;118(4):488]. Arch Ophthalmol. 1999;117(10):1329-1345.
9. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389-393.
10. Harding JJ, Dilley KJ. Structural proteins of mammalian lens: review with emphasis on changes in development, aging and cataract. Exp Eye Res. 1976;22(1):1-73.
11. Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol. 1983;96(6):710-715.
12. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol. 1994;118(4):445-450.
13. Machemer R, Laqua H. Pigment epithelium proliferation in retinal detachment (massive periretinal proliferation). Am J Ophthalmol. 1975;80(1):1-23.
14. Heeger DJ. Normalization of cell responses in cat striate cortex. Vis Neurosci. 1992;9(2):181-197.
15. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2:187-199.
16. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113(3):325-332.
17. Sarks SH. Aging and degeneration in the macular region: a clinicopathological study. Br J Ophthalmol. 1976;60(5):324-341.
18. Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology. 1991;98(3):317-321.
19. Bailey IL, Lovie JE. New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976;53(11):740-745.
20. Apple DJ, Solomon KD, Tetz MR, et al. Posterior capsule opacification. Surv Ophthalmol. 1992;37:73-116.
21. Bird AC, Bressler NM, Bressler SB, et al; International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol. 1995;39(5):367-374.
22. Young RW. Visual cells and concept of renewal. Invest Ophthalmol. 1976;15:700-725.
23. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology. 1983;90(8):859-873.
24. Bressler NM, Bressler SB, Fine SL. Age-related macular degeneration. Surv Ophthalmol. 1988;32(6):375-413.
25. Cunha-Vaz J, Faria de Abreu JR, Campos AJ. Early breakdown of blood retinal barrier in diabetes. Br J Ophthalmol. 1975;59(11):649-656.
26. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109(5):654-659.
27. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY. Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology. 1985;92(4):472-484.
28. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res. 1981;33(6):673-681.
29. Steinberg EP, Tielsch JM, Schein OD, et al. The VF-14: an index of functional impairment in patients with cataract. Arch Ophthalmol. 1994;112(5):630-638.
30. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion-cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36(5):774-786.
31. Bressler NM; Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP report 2. Arch Ophthalmol. 2001;119(2):198-207.
32. Gospodarowicz D, Mescher AL, Birdwell CR. Stimulation of corneal endothelial cell proliferation in vitro by fibroblast and epidermal growth factors. Exp Eye Res. 1977;25(1):75-89.
33. Chylack LT Jr, Wolfe JK, Singer DM, et al; Longitudinal Study of Cataract Study Group. The lens opacities classification system III. Arch Ophthalmol. 1993;111(6):831-836.
34. Wise JB, Witter SL. Argon laser therapy for openangle glaucoma: a pilot study. Arch Ophthalmol. 1979;97(2):319-322.
35. Gass JD. Idiopathic senile macular hole: its early stages and pathogenesis. Arch Ophthalmol. 1988;106(5):629-639.
36. Age-Related Eye Disease Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS report No. 8. Arch Ophthalmol. 2001;119(10):1417-1436.
37. Puliafito CA, Hee MR, Lin CP, et al. Imaging of macular diseases with optical coherence tomography. Ophthalmology. 1995;102(2):217-229.
38. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol. 1991;109(12):1693-1698.
39. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion-cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol. 1989;107(5):453-464.
40. Abramson DH, Ellsworth RM, Kitchin FD, Tung G. Second nonocular tumors in retinoblastoma survivors: are they radiation-induced? Ophthalmology. 1984;91(11):1351-1355.
41. Jabs DA, Enger C, Bartlett JG. Cytomegalovirus retinitis and acquired immunodeficiency syndrome. Arch Ophthalmol. 1989;107(1):75-80.
42. Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin vs postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology. 1992;99(3):438-444.
43. Zimmerman TJ, Kaufman HE. Beta-adrenergic blocking-agent for treatment of glaucoma. Arch Ophthalmol. 1977;95(4):601-604.
44. Wilson HR, Ferrera VP, Yo C. A psychophysically motivated model for 2-dimensional motion perception. Vis Neurosci. 1992;9(1):79-97.
45. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109(1):77-83.
46. Bourne WM, Kaufman HE. Specular microscopy of human corneal endothelium in vivo. Am J Ophthalmol. 1976;81(3):319-323.
47. Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol. 1987;31(5):291-306.
48. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994;35(1):101-111.
49. Seiler T, Wollensak J. Myopic photorefractive keratectomy with the excimer laser: one-year follow-up. Ophthalmology. 1991;98(8):1156-1163.
50. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS) 7: The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429-440.
51. Leske MC, Chylack LT Jr, Wu SY. The lens opacities case-control study: risk factors for cataract. Arch Ophthalmol. 1991;109(2):244-251.
52. Alm A, Stjernschantz J; Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology. 1995;102(12):1743-1752.
53. Camras CB; US Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology. 1996;103(1):138-147.
54. Palestine AG, Rodrigues MM, Macher AM, et al. Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology. 1984;91(9):1092-1099.
55. Sommer A, Tielsch JM, Katz J, et al. Relationship between intraocular pressure and primary open-angle glaucoma among white and black Americans: the Baltimore Eye Survey. Arch Ophthalmol. 1991;109(8):1090-1095.
56. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: visual acuity. Ophthalmology. 1991;98(8):1310-1315.
57. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713.
58. Fantes FE, Hanna KD, Waring GO III, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990;108(5):665-675.
59. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma, II: the site of injury and susceptibility to damage. Arch Ophthalmol. 1981;99(4):635-649.
60. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology. 1992;99(11):1647-1654.
61. International Standardization Committee. Standard for clinical electroretinography. Arch Ophthalmol. 1989;107(6):816-819.
62. Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114(3):299-305.
63. Kenyon KR, Tseng SCG. Limbal autograft transplantation for ocular surface disorders. Ophthalmology. 1989;96(5):709-723.
64. Cousins SW, McCabe MM, Danielpour D, Streilein JW. Identification of transforming growth factor beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci. 1991;32(8):2201-2211.
65. Tielsch JM, Sommer A, Witt K, Katz J, Royall RM. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch Ophthalmol. 1990;108(2):286-290.
66. Kattan HM, Flynn HW, Pflugfelder SC Jr, Robertson C, Forster RK. Nosocomial endophthalmitis survey: current incidence of infection after intraocular surgery. Ophthalmology. 1991;98(2):227-238.
67. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: the Blue Mountains Eye Study. Ophthalmology. 1995;102(10):1450-1460.
68. Zimmerman LE, McLean IW, Foster WD. Does enucleation of eye containing a malignant melanoma prevent or accelerate dissemination of tumor cells. Br J Ophthalmol. 1978;62(6):420-425.
69. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology. 1980;87(10):1044-1049.
70. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol. 1981;99(8):1445-1454.
71. Quigley HA, Dunkelberger GR, Green WR. Chronic human glaucoma causing selectively greater loss of large optic nerve fibers. Ophthalmology. 1988;95(3):357-363.
72. Green WR, Enger C. Age-related macular degeneration histopathologic studies: the 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993;100(10):1519-1535.
73. Watson P, Stjernschantz J; The Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology. 1996;103(1):126-137.
74. Apple DJ, Mamalis N, Loftfield K, et al. Complications of intraocular lenses: a historical and histopathological review. Surv Ophthalmol. 1984;29(1):1-54.
75. Pavlin CJ, Harasiewicz K, Sherar MD, Foster ES. Clinical use of ultrasound biomicroscopy. Ophthalmology. 1991;98(3):287-295.
76. Quigley HA, Sanchez RM, Dunkelberger GR, L'Hernault NL, Baginski TA. Chronic glaucoma selectively damages large optic nerve fibers. Invest Ophthalmol Vis Sci. 1987;28(6):913-920.
77. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma: the Beaver Dam Eye Study. Ophthalmology. 1992;99(10):1499-1504.
78. Pallikaris IG, Siganos DS. Excimer laser in-situ keratomileusis and photorefractive keratectomy for correction of high myopia. J Refract Corneal Surg. 1994;10(5):498-510.
79. Bignami A, Dahl D. Radial glia of Muller in the rat retina and their response to injury: immunofluorescence study with antibodies to the glial fibrillary acidic (GFA) protein. Exp Eye Res. 1979;28(1):63-69.
80. Johnston MC, Noden DM, Hazelton RD, Coulombre JL, Coulombre AJ. Origins of avian ocular and periocular tissues. Exp Eye Res. 1979;29(1):27-43.
81. Nussenblatt RB, Palestine AG, Chan CC. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol. 1983;96(3):275-282.
82. Holly FJ, Lemp MA. Tear physiology and dry eyes. Surv Ophthalmol. 1977;22(2):69-87.
83. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117(5):603-624.
84. Machemer R, van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85(2):181-191.
85. Skuta GL, Parrish RK II. Wound healing in glaucoma filtering surgery. Surv Ophthalmol. 1987;32(3):149-170.
86. Munnerlyn CR, Koons SJ, Marshall J. Photorefractive keratectomy: a technique for laser refractive surgery. J Cataract Refract Surg. 1988;14(1):46-52.
87. Attebo K, Mitchell P, Smith W. Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology. 1996;103(3):357-364.
88. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic neovascularization. Verteporfinin photodynamic therapy report 2. Am J Ophthalmol. 2001;131(5):541-560.
89. Bok D. Retinal photoreceptor-pigment epithelium interactions: Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1985;26(12):1659-1694.
90. Littmann H. Determination of the real size of an object on the fundus of the living eye [in German]. Klin Monatsbl Augenheilkd. 1982;180(4):286-289.
91. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98(7):1128-1134.
92. Laing RA, Sanstrom MM, Berrospi AR, Leibowitz HM. Changes in corneal endothelium as a function of age. Exp Eye Res. 1976;22(6):587-594.
93. Waring GO III, Bourne WM, Edelhauser HF, Kenyon KR. The corneal endothelium: normal and pathologic structure and function. Ophthalmology. 1982;89(6):531-590.
94. Gartry DS, Kerr Muir MG, Marshall J. Excimer laser photorefractive keratectomy: 18-month follow-up. Ophthalmology. 1992;99(8):1209-1219.
95. Martin DF, Parks DJ, Mellow SD, et al. Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial. Arch Ophthalmol. 1994;112(12):1531-1539.
96. Spector A. The search for a solution to senile cataracts: Proctor Lecture. Invest Ophthalmol Vis Sci. 1984;25(2):130-146.
97. Macular Photocoagulation Study Group. Argon-laser photocoagulation for neovascular maculopathy: 5-year results from randomized clinical trials [published correction appears in Arch Ophthalmol. 1992;110(6):761]. Arch Ophthalmol. 1991;109(8):1109-1114.
98. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study (EVS): a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113(12):1479-1496.
99. Yablonski ME, Zimmerman TJ, Waltman SR, Becker B. Fluorophotometric study of effect of topical timolol on aqueous-humor dynamics. Exp Eye Res. 1978;27(2):135-142.
100. Scott AB, Kennedy RA, Stubbs HA. Botulinum: a toxin injection as a treatment for blepharospasm. Arch Ophthalmol. 1985;103(3):347-350.
101. Klein BE, Klein R, Linton KL. Prevalence of age-related lens opacities in a population: the Beaver Dam Eye Study. Ophthalmology. 1992;99(4):546-552.
102. Adamis AP, Shima DT, Tolentino MJ, et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol. 1996;114(1):66-71.
103. Campbell FM. National bias: a comparison of citation practices by health professionals. Bull Med Libr Assoc. 1990;78(4):376-382.
104. Link AM. US and non-US submissions. JAMA. 1998;280(3):246-247.